Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Zinc finger protein 42 homolog (70-150 aa) is suitable for use in Western Blot and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000ELISA 1:5000-20000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
ZFP42 |
Gene ID: |
132625 |
Uniprot ID: |
ZFP42_HUMAN |
Immunogen Region: |
70-150 aa |
Specificity: |
ZFP42 Polyclonal Antibody detects endogenous levels of protein. |
Immunogen: |
Synthesized peptide derived from the human protein at the amino acid range 70-150 |
Post Translational Modifications | Polyubiquitinated by RNF12, leading to proteasomal degradation. |
Function | Involved in the reprogramming of X-chromosome inactivation during the acquisition of pluripotency. Required for efficient elongation of TSIX, a non-coding RNA antisense to XIST. Binds DXPas34 enhancer within the TSIX promoter. Involved in ES cell self-renewal. |
Protein Name | Zinc Finger Protein 42 HomologZfp-42Reduced Expression Protein 1Rex-1Hrex-1Zinc Finger Protein 754 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Zinc Finger Protein 42 Homolog antibodyAnti-Zfp-42 antibodyAnti-Reduced Expression Protein 1 antibodyAnti-Rex-1 antibodyAnti-Hrex-1 antibodyAnti-Zinc Finger Protein 754 antibodyAnti-ZFP42 antibodyAnti-REX1 antibodyAnti-ZNF754 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance